Back to search

University of Patras

Βιοχημική και μοριακή μελέτη των γλυκοζαμινογλυκανών και των ενζύμων μεταβολισμού τους στον καρκίνο

Abstract

dc:description

Sulfated glycosaminoglycans are important molecules of the extracellular matrix. Their biosynthesis is accomplished by the contribution of many different enzymes which have distinct roles. The most important enzymes in the chondroitin/ dematan sulfate biosynthesis are chondroitin synthases, glycosyltransferases, sulfotransferases and dermatan sulfate epimerase (DSE). Chondroitin synthases possess dual role containing two different active sites: One adding glucuronic acid and one adding N-acetylgalacosamine in the non-reducing end of a synthesizing chain. In parallel, sulfotransferases modify the newly-synthesized chains by adding sulfate in certain positions. The chondroitin synthases are CHSY1, CHSY2 (CHPF) and CHSY3. The glycosyltransferase acting in chondroitin is CSGlcA-T. Prior to sulfation, dermatan sulfate epimerase converts glucuronic acid to iduronic. The main sulfotransferases are C4ST1, D4ST1 and CHST3. CHST3 and C4ST1 acting mainly in chondroitin whereas D4ST1 acts mainly in dermatan. It was observed that the various glycosaminoglycans undergo many alterations in quantitative and qualitative terms. These alterations seem to contribute in cancer development and progression as well as in cancer phenotype. The deep understanding of the mechanisms which lead in glycosaminoglycan changes is of great importance. The study focuses in the variation of the levels of the chondroitin / dermatan polymerizing and modifying enzymes in healthy and cancerous tissues (both macroscopically normal and pathological specimens) in colorectal and laryngeal cancer.RT-PCR analysis was carried out to determine the expression of these enzymes after RNA isolation. For Western blotting tissue samples were subjected to sequential extraction with PBS, 4 M guanidine hydrochloride and 4 M guanidine hydrochloride – 1% Triton X-100. For epigenetic studies, methylation-specific PCR was carried out after DNA isolation. Furthermore, we have examined the levels of other molecules (decorin, versican isoforms and miR124) to find out if their presence can be correlated with the obtained enzymes’ profile. In colorectal samples, chondroitin synthase I expression was higher in the adjacent normal tissue of the benign tumors. In healthy tissues and benign tumors the enzyme was expressed in trivial amounts. In cancer, its expression was high at early stages. In laryngeal samples, chondroitin synthase I was expressed mainly in the pathologic samples and to a lower extent in the healthy specimens. Trivial amounts of the enzyme were detected in the pathologic samples. Chondroitin polymerizing factor was found to be elevated in colorectal cancer in the pathologic specimens compared to macroscopically normal. Furthermore, its mRNA levels had the tendency to elevate progressively with cancer stage in the pathologic specimens. In healthy samples and the adjacent normal specimens of the benign tumors its expression was trivial. In contrast in laryngeal samples the enzyme was elevated in the healthy tissues. In colorectal tissues CSGlcA-T expression was increased in adenomas (in the pathological parts) and in advanced stages of the disease. In the middle stages its expression is relatively suppressed and the tumors possess the same amount of the enzyme with the adjacent macroscopically normal tissue. No significant differences between macroscopically normal and pathologic specimens were observed at the levels of chondroitin-6-sulfotransferase and chondroitin synthase III in both laryngeal and colorectal cancer. Besides, in healthy larynx the specified enzymes were expressed intensively compared to cancer but the opposite profile was obtained in colon. In colorectal cancer, dermatan-4-sulfotransferase mRNA levels were in decreasing amounts in both macroscopically normal and cancerous tissues but its protein levels were constant in cancer. In laryngeal samples D4ST1 was expressed mainly in the healthy tissues but the oppοsite profile was obtained for colorectal samples. The CpG island near the promoter region of the D4ST1 gene in both colorectal and laryngeal cancer was fully unmethylated therefore it did not affect the enzyme expression another regulatory mechanism(s) should be considered. C4ST1 levels were trivial in healthy tissues and pre-cancerous situations in colon samples. In advanced stages C4ST1 was expressed about at the same levels in both normal and cancerous specimens. Its promoter was heavily methylated in the pathologic specimens but the unmethylated allele was not intense possibly due to semimethylation. In laryngeal tissues, C4ST1 gene expression was very low in healthy specimens and increased in patients' specimens. Its expression seemed to be controlled via methylation of a CpG island, since hypomethylation of the gene was observed in the pathologic samples compared to the macroscopically normal samples RT-PCR analysis indicated that in colorectal cancer dermatan sulfate epimerase mRNA levels were elevated in the pathologic specimens in the advanced stages. ...

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kalathas, Dimitrios
  • Καλαθάς, Δημήτριος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25866

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kalathas, Dimitrios; Καλαθάς, Δημήτριος. Βιοχημική και μοριακή μελέτη των γλυκοζαμινογλυκανών και των ενζύμων μεταβολισμού τους στον καρκίνο. University of Patras, 2011. http://hdl.handle.net/10442/hedi/25866